Imudon® (Imudon®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceLysates of microorganisms [Candida albicans + Corynebacterium pseudodiphtheriticum + Enterococcus faecalis + Enterococcus faecium + Fusobacterium nucleatum subsp]Lysates of microorganisms [Candida albicans + Corynebacterium pseudodiphtheriticum + Enterococcus faecalis + Enterococcus faecium + Fusobacterium nucleatum subsp]
Similar drugsTo uncover
  • Imudon®
    pills locally inwards 
    PHARMSTANDART-TOMSKHIMFARM, OJSC     Russia
    • Dosage form: & nbsplozenges
    Composition:

    For one tablet

    The drug is a multivalent antigenic complex, a mixture of bacterial lysates, whose composition corresponds to pathogens, most often causing inflammation in the oral cavity and pharynx.

    Active ingredient:

    Imudon® (a mixture of bacterial lysates) - 2.7 mg

    (in terms of dry matter):

    including:

    bacterial lysates: [L. acidophilus + L. delbrueckii ss lactis + L. helveticus + L. fermentum + S. pyogenes groupe A + S. sanguis groupe H + S. aureus + E. faecium + E. faecalis + K. pneumoniae ss pneumoniae + F. nucleatum ss fusiforme + C. pseudodiphtheriticum + C. albicans] - 0.1575 mg and excipients: glycine - 2.0 mg, sodium deoxycholate - 0.53 mg, thiomersal - not more than 0.0125 mg.

    Excipients:

    glycine - 47.3 mg, lactose monohydrate 350 mg, mannitol 100 mg, sodium saccharinate 1.12 mg, povidone 10.0 mg, sodium hydrogen carbonate 30.0 mg, citric acid anhydrous 23.0 mg, flavoring mint-8,0 mg, magnesium stearate - 4.88 mg.

    Description:

    Tablets of white or almost white color, flat-cylindrical shape, with a smooth shiny surface, with bevelled edges, with a mint smell, slight marble is allowed.

    Pharmacotherapeutic group:Immunostimulating agent
    ATX: & nbsp

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:

    Immunostimulating drug of bacterial origin for topical application in otorhinolaryngology, dentistry. Activates phagocytosis, promotes an increase in the number of immunocompetent cells, increases the production of lysozyme and interferon, and immunoglobulin A in saliva.

    Indications:

    Treatment and prevention of infectious and inflammatory diseases of the oral cavity and pharynx:

    - pharyngitis;

    - chronic tonsillitis;

    - Preoperative preparation and postoperative period after tonsillectomy;

    - superficial and deep periodontitis, periodontitis, stomatitis (including aphthous), glossitis;

    - erythematous and ulcerative gingivitis;

    - dysbacteriosis of the oral cavity;

    - infection after tooth extraction, implantation of artificial dental roots;

    - ulceration caused by dentures.

    Contraindications:

    - Increased individual sensitivity to the drug or its components;

    - children up to 3 years;

    - autoimmune diseases.

    Pregnancy and lactation:

    Information on the use of Imudon in pregnant women is not enough. Corresponding data on animal experiments and epidemiological studies are lacking.

    It is not recommended to take Imudon® during pregnancy or lactation.

    Dosing and Administration:

    For adults and teenagers over 14 years.

    When acute inflammatory diseases oral and pharyngeal cavities and exacerbation of chronic diseases the drug is taken on 8 tablets a day. Tablets dissolve (not chewing) in the oral cavity with an interval of 1-2 hours. The average duration of the course of treatment is 10 days.

    For prevention of exacerbation of chronic inflammatory diseases oral cavity and pharynx drug take 6 tablets per day. Tablets dissolve (not chewing) in the oral cavity with an interval of 2 hours. Duration of the course is 20 days. It is recommended to conduct preventive courses of treatment with Imudon 3-4 times a year.

    For children from 3 to 14 years.

    When treatment of acute and exacerbation of chronic inflammatory diseases oral cavity and pharynx, and for the prevention of the drug used on 6 tablets a day. Tablets dissolve (not chewing) in the oral cavity with an interval of 1-2 hours. Duration of treatment for acute diseases 10 days, for prevention exacerbations chronic diseases - 20 days.The course of preventive use is recommended to be repeated 3-4 times a year.

    Side effects:

    In rare cases, the use of the drug may be accompanied by allergic reactions (rash, hives, angioedema), reactions from the gastrointestinal tract (nausea, vomiting, abdominal pain), fever, exacerbation of bronchial asthma, cough. In very rare cases, the use of the drug may be accompanied by the development of nodular erythema, hemorrhagic vasculitis, thrombocytopenia.

    Overdose:

    Cases of an overdose of Imudon are not described.

    Interaction:Not noted. Imudon ® can be used with drugs from other groups.
    Special instructions:

    - Children from 3 to 6 years dissolve tablets under the mandatory supervision of adults!

    - Do not take food and water, and rinse your mouth for an hour after applying Imudon, so as not to reduce the therapeutic effectiveness of the drug.

    - When prescribing a drug that complies with a salt-free or low-salt diet, it should be noted that 1 Imudon tablet contains 15 mg Na+.

    - patients with bronchial asthma, in whom taking drugs containing bacterial lysates,causes an exacerbation of the disease (attack of bronchial asthma), the drug is not recommended.

    Effect on the ability to drive transp. cf. and fur:

    There is no evidence of the need for any restrictions on activities related to driving or other mechanisms during the treatment period.

    Form release / dosage:Lozenges.
    Packaging:

    For 8 tablets in a contour mesh package (blister) of composite material polyamide / aluminum / PVC and aluminum foil printed lacquered.

    3 or 5 contour cell packs (blisters) of 8 tablets together with instructions for use are placed in a pack of cardboard.

    Storage conditions:

    Store and transport in accordance with SP 3.3.2.1248-03 at a temperature not higher than 25 ° C. Keep out of the reach of children.

    Shelf life:2 years.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N014990 / 01
    Date of registration:08.05.2009 / 02.08.2010
    Expiration Date:Unlimited
    The owner of the registration certificate:PHARMSTANDART-TOMSKHIMFARM, OJSC PHARMSTANDART-TOMSKHIMFARM, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp07.11.2017
    Illustrated instructions
      Instructions
      Up